Back

Cavotricuspid isthmus ablation by means of very high power short duration temperature controlled lesions: acute and mid term outcome

16 April 2023 (15:40 - 16:40)
Organised by:
Congress Presentation Part of: Supraventricular Tachycardia (Non-Atrial Fibrillation) Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Vincenzo Schillaci

Montevergine Clinic, Mercogliano (Italy)

8 More presentations in this session

Presentation thumbnail
Novel inflammatory biomarkers in postural orthostatic tachycardia syndrome
Doctor M. Johansson (Malmo, SE)
Abstract Slides
Presentation thumbnail
Spontaneous variation of ventriculoatrial interval after tachycardia induction: determinants and usefulness in the diagnosis of supraventricular tachycardias with long ventriculoatrial interval.
Doctor O. Duran Bobin (Talavera de la Reina, ES)
Abstract Slides
Presentation thumbnail
Wave speed guided point-by-point cavo-tricuspid isthmus ablation to reduce ablation and fluoroscopy in typical atrial flutter
Doctor E. Valles Gras (Barcelona, ES)
Abstract Slides
Presentation thumbnail
Voltage and propagation mapping: new tools to improve successful ablation of atrioventricular nodal reentry tachycardia.
Doctor C. Devecchi (Vercelli, IT)
Abstract Slides
Presentation thumbnail
Outcomes of cavotricuspid isthmus-dependent fLutter ablation: randomized study comparing single vs multiple catheter procedures. The SIMPLE study
Doctor G. Falasconi (Barcelona, ES)
Abstract Slides

Access the full session

Session thumbnail
Supraventricular Tachycardia (Non-Atrial Fibrillation)

The Event

Event poster

EHRA 2023

16 April 2023 15:40 CET
You may be interested in
thumbnail
Congress Presentation
A new criterium for optimal energy application in ultra-high-power short-duration ablation
thumbnail
Congress Presentation
Peri-procedural anesthesia and patient pain experience in pulmonary vein isolation by means of very high power short duration radiofrequency ablation.
thumbnail
Congress Presentation
Characterization of high-power and very-high-power short-duration radiofrequency lesions performed with a new-generation catheter and a temperature-control ablation mode

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources